APN 2022 - November 9-10

Dear Colleagues, This is the second announcement of the 2022 Asian Pharmacometrics Network (APN) symposium to be held virtually on November 9-10. Following previous years, speakers this year were also invited from various Asian countries (11 Asian countries), keeping making it the unique Asian meeting fully representing the diversity of the region. Registration is free and its procedure and the program are found at https://pagmas.github.io/apn-2022/ A satellite workshop titled “Hands on with Monolix” is scheduled on November 7-8 prior to the symposium, the detail of which will be found at https://pagmas.github.io/apn-2022/preconference.html For more information, contact the local host Dr. Lo Yoke Lin of International Medical University, Malaysia at [email protected]<mailto:[email protected]> or APN Symposium Secretariat at [email protected]<mailto:[email protected]> With 16 member countries currently, APN has kept organizing its meeting to be as diverse as possible since its inaugural meeting in 2019, which is to fulfill the APN’s goal of enhancing and expanding regional development and networking opportunities in pharmacometrics in the Asian region. For more information, you may want to look at the following paper recently published in CPT: PSP. The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities. CPT: Pharmacometrics & Systems Pharmacology. 11(4):403-408 (Apr 2022) Best regards, APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 Email [email protected]<mailto:[email protected]> 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.